Journal for ImmunoTherapy of Cancer (Nov 2023)
1370 Anti-PD-1/IL-7v immunocytokine favors proliferation & survival of TCF1+ stem like memory T cells and a durable in vivo efficacy in monotherapy or using combinatorial strategy
Abstract
No abstracts available.